Spending decline
The impact of price disclosure has been again confirmed by Department of Health data forecasting falling PBS expenditure The latest figures reveal Government spending on the PBS is forecast …
Making change work to benefit our profession
Healthcare reform is well and truly underway in Australia and will continue over the coming years, says Joe Demarte In the face of this, our profession needs to ensure that …
Risk share debate heats up
The dispute between the Pharmacy Guild of Australia and the Federal government over 6CPA risk sharing agreements seems set to roll on into 2017 Articles in Fairfax media sources last …
Warning on biosimilar burden
A higher than usual degree of pharmacovigilance is required when patients are switched to new biosimilar medications, say Australian experts Writing in the latest Australian Prescriber two pharmacy academics have stressed …
Pharmacy retail ratings released
Discounters lead the way in pharmacy retail satisfaction survey The co-owned My Chemist and Chemist Warehouse chains have monopolised the pharmacy retail honours in the recent Roy Morgan Customer Satisfaction …
Cap problem leads to recall
Anticonvulsant recalled due to issue with child-resistant caps Pfizer Australia, in consultation with the TGA, has initiated a recall for product correction for bottles of phenytoin 30 mg capsules, 100 …
Is AHPRA a “partly failed” experiment?
Questions raised over the success of our national healthcare professional registration scheme Australia’s five-year-old national registration scheme for healthcare practitioners is flawed, an academic has claimed. Writing in the Australian …
Facing the consequences
Pharmacists are much more likely than doctors to receive a regulatory penalty if they are subject to a notification for unsafe practice, new study reveals An analysis of all notifications …
A shot in the arm
New study provides another boost for the reach and efficacy of pharmacist influenza vaccination A wide range of Australians who would otherwise not be vaccinated against influenza would do so …
The 10 most expensive drugs
New Hepatitis C medicines a costly solution at the top of the most expensive drugs list Newly approved hepatitis C medicines have topped the latest list of the most costly …
Asthma treatment now on PBS
New biologic to treat severe asthma heads new PBS listings The first biologic medicine to treat severe allergic asthma in patients whose symptoms are inadequately controlled with high dose preventer …
Pharmacists unsure over codeine future
Poll reveals strong division among profession on what will happen to codeine-containing medications The pharmacy profession is unsure over whether codeine-containing medications will be upscheduled, according to the latest AJP …